Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Regulatory approval is next: Mizuho lifts Biogen to buy on news of Alzheimer’s drug success By: MarketWatch September 28, 2022 at 02:45 AM EDT Biogen and partner Eisai late Tuesday reported positive results from a late stage, large trial of their experimental Alzheimer's drug. Read More >> Related Stocks: Biogen Idec Eli Lilly Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Regulatory approval is next: Mizuho lifts Biogen to buy on news of Alzheimer’s drug success By: MarketWatch September 28, 2022 at 02:45 AM EDT Biogen and partner Eisai late Tuesday reported positive results from a late stage, large trial of their experimental Alzheimer's drug. Read More >> Related Stocks: Biogen Idec Eli Lilly